Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

CIK: 0001715579 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 1, 2024

Total Value ($000): $296,230 (100.0% shares, 0.0% debt)

Holdings (5)

CNTA CENTESSA PHARMACEUTICALS PLC 53.6%

Value ($000) $158,907 Shares 19,963,157 Est. Cost $20.88 Unrealized —

— MERUS N V 14.9%

Value ($000) $44,000 Shares 1,600,000 Est. Cost $14.08 Unrealized —

PHAT PHATHOM PHARMACEUTICALS INC 11.6%

Value ($000) $34,337 Shares 3,760,869 Est. Cost $18.86 Unrealized -54.3%

NAMS NEWAMSTERDAM PHARMA COMPANY 10.8%

Value ($000) $32,053 Shares 2,869,565 Est. Cost $10.96 Unrealized -16.4%

AURA AURA BIOSCIENCES INC 9.1%

Value ($000) $26,933 Shares 3,039,892 Est. Cost $17.87 Unrealized -52.6%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$158,907	53.6%	$20.88	—	SPONSORED ADS	152309100
—	MERUS N V	1,600,000	$44,000	14.9%	$14.08	—	COM	N5749R100
PHAT	PHATHOM PHARMACEUTICALS INC	3,760,869	$34,337	11.6%	$18.86	-54.3%	COM	71722W107
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,869,565	$32,053	10.8%	$10.96	-16.4%	ORDINARY SHARES	N62509109
AURA	AURA BIOSCIENCES INC	3,039,892	$26,933	9.1%	$17.87	-52.6%	COM	05153U107